XP Inc (XP) concluded trading on Wednesday at a closing price of $16.10, with 4.57 million shares of worth about $73.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.63% during that period and on April 30, 2025 the price saw a loss of about -0.37%. Currently the company’s common shares owned by public are about 434.05M shares, out of which, 372.77M shares are available for trading.
Stock saw a price change of 6.91% in past 5 days and over the past one month there was a price change of 17.09%. Year-to-date (YTD), XP shares are showing a performance of 35.86% which decreased to -23.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.82 but also hit the highest price of $22.80 during that period. The average intraday trading volume for XP Inc shares is 7.57 million. The stock is currently trading 12.98% above its 20-day simple moving average (SMA20), while that difference is up 10.92% for SMA50 and it goes to 2.47% higher than SMA200.
XP Inc (NASDAQ: XP) currently have 434.05M outstanding shares and institutions hold larger chunk of about 60.39% of that.
The stock has a current market capitalization of $8.65B and its 3Y-monthly beta is at 1.18. PE ratio of stock for trailing 12 months is 10.53, while it has posted earnings per share of $1.53 in the same period. Its PEG reads 0.87 while making debt-to-equity ratio of 4.78. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XP, volatility over the week remained 2.89% while standing at 4.22% over the month.
Stock’s fiscal year EPS is expected to rise by 11.75% while it is estimated to increase by 12.94% in next year. EPS is likely to shrink at an annualized rate of 12.17% for next 5-years, compared to annual growth of 23.61% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Itau BBA on March 18, 2025 offering an Outperform rating for the stock and assigned a target price of $20 to it. Coverage by UBS stated XP Inc (XP) stock as a Buy in their note to investors on January 24, 2025, suggesting a price target of $16 for the stock. On December 10, 2024, BofA Securities Downgrade their recommendations, while on July 11, 2024, UBS Downgrade their ratings for the stock with a price target of $21. Stock get a Neutral rating from Goldman on April 30, 2024.
